查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
三叉神經痛治療的全球市場-成長，未來展望，競爭分析(2022年～2030年)
市場調查報告書
商品編碼
1192923

三叉神經痛治療的全球市場-成長，未來展望，競爭分析(2022年～2030年)

Trigeminal Neuralgia Treatment Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日期: | 出版商: Acute Market Reports | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格

全球三叉神經痛治療的市場規模，從2022年到2030年的預測期間內將以18％的年複合成長率成長，預計達到400億美元。支援藥物療法的使用增加的患者支援型的償付政策，國民的意識提升伴隨的高齡化的發展，外科治療的技術進步，促進市場成長。

本報告提供全球三叉神經痛治療市場相關調查分析，市場動態，市場分析，企業簡介等系統性資訊。

目錄

第1章 序文

  • 報告的說明
    • 報告的目的
    • 目標受眾
    • 主要的產品
  • 市場區隔
  • 調查手法
    • 階段Ⅰ-2次調查
    • 階段Ⅱ-1次調查
    • 階段Ⅲ-專家的審查
    • 假設
    • 所採用的方法

第2章 摘要整理

  • 市場概述:全球三叉神經痛治療市場
  • 全球三叉神經痛治療市場(100萬美元)(2021年):各治療
  • 全球三叉神經痛治療市場(100萬美元):各地區
  • 富有魅力的投資提案(2021年):各地區

第3章 三叉神經痛治療市場:競爭分析

  • 主要的三叉神經痛治療市場供應商的市場定位
  • 三叉神經痛治療市場供應商採用的策略
  • 主要的產業策略
  • 階層分析:2021年和2030年的比較

第4章 三叉神經痛治療市場:常量分析和市場動態

  • 簡介
  • 全球三叉神經痛治療市場金額(100萬美元)(2020年～2030年)
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 主要課題
    • 主要的機會
  • 促進因素與阻礙因素的影響分析
  • See-Saw分析

第5章 三叉神經痛治療市場，美金(100萬)(2020年～2030年):各治療

  • 市場概要
  • 成長和收益分析::2021年和2030年的比較
  • 市場區隔
    • 藥物
    • 手術

第6章 北美的三叉神經痛治療市場，美金(100萬)(2020年～2030年)

第7章 英國及歐洲聯盟的三叉神經痛治療市場，美金(100萬)(2020年～2030年)

第8章 亞太地區三叉神經痛治療市場，美金(100萬)(2020年～2030年)

第9章 南美的三叉神經痛治療市場，美金(100萬)(2020年～2030年)

第10章 中東及非洲的三叉神經痛治療市場，美金(100萬)(2020年～2030年)

第11章 企業簡介

  • Allergan Plc
  • Biogen, Inc.
  • Kineta Inc.
  • Merz Pharma GmbH & Co.
  • Trigemina Inc.
  • Abbott Laboratories
  • Pfizer Inc.
  • GlaxoSmithKline Plc.
  • Novartis
  • Shire
Product Code: 137227-08-22

This report on global trigeminal neuralgia treatment market studies various drugs used for treatment of trigeminal neuralgia along with pipeline analysis of upcoming potential drugs. Trigeminal neuralgia is a chronic pain condition that affects the trigeminal nerve, which carries sensation from face to brain. According to the International Association for the Study of Pain the incidence of Trigeminal Neuralgia is 12 per 100,000 persons per year. The etiology includes the compression of blood vessels, degeneration of arteries, myelin sheath infiltration and idiopathy. Trigeminal neuralgia is most commonly seen after the age of 40 years more common in female. Thus, drug pipeline of trigeminal neuralgia treatment market comprises potential drugs which are more target-specific and possess innovative properties.

For the purpose of this study, the various treatment types studied includes drug based therapy and surgical procedures; further, drug based therapy are segmented as anticonvulsant drugs, NSAIDs, and opioids.

The pipeline analysis for trigeminal neuralgia treatment market comprises projected market sales of Phase III drugs estimated till 2025. We have estimated sales of very specific molecules based on the type (chemical-based or biological), sponsor, depicted peak sales by leading market experts and other factors.

The geographic segmentation of the global trigeminal neuralgia treatment market is performed for the regions North America, Europe, Asia-Pacific, Latin America and Middle East and Africa markets. The regions are also further sub-segmented on the basis of major countries.

Trigeminal neuralgia is a chronic pain condition that affects the trigeminal nerve, which carries sensation from face to brain. The etiology includes the compression of blood vessels, degeneration of arteries, myelin sheath infiltration and idiopathic. According to American Association of Neurological Surgeons 150,000 people are diagnosed with Trigeminal Neuralgia.

According to market experts, drug based therapy is increasingly used to treat in developed markets, but application is still low in emerging markets, carbamazepine being the only approved drug in the market which is considered as the first line therapy followed by NSAIDs and opioids. However, the drug related side effects are high, so patients are opting for various types of surgical procedures for the treatment of trigeminal neuralgia like micro-vascular decompression, rhizotomy, and stereotactic radiosurgery. In base year 2021, drug based therapy accounted for the major market share in the treatment around 71% followed by surgical procedures which accounts for remaining 29% for patients those are not responding to drug therapy. During the forecast period 2022 - 2030 drug based therapy are expected to project a significant growth. The key factors assisting the segment growth comprises patient-supportive reimbursement policies that has assisted the increased use drug based therapy in developed markets, rise in aging population coupled with growing public awareness, and technological advancements in the surgical procedures.

North America was observed as the largest market for trigeminal neuralgia treatment in the base year 2021 due to rise in aging population and technological advancement in diagnostic tests. Europe is expected to be the second largest market due to rising public awareness, healthcare infrastructure and penetration of new technologies. According to American Association of Neurological Surgeons150,000 people are diagnosed with Trigeminal Neuralgia. Growth in Asia-Pacific in trigeminal neuralgia treatment market is attributed by factors like rising prevalence of neuropathic pain diseases, increasing investments in R&D and higher disposable income in these regions. However, factors such as developing health infrastructure, increasing awareness among people about health care and aging population are going to fuel the rapid growth of Trigeminal neuralgia disease treatment market in Latin America and Middle East and Africa region in the near future.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Trigeminal Neuralgia Treatment market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Trigeminal Neuralgia Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Treatment

Drug Based

Anticonvulsant

NSAIDs

Opioids

Surgery

Rhizotomy

Stereotactic radiosurgery

Micro vascular decompression

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

Pre COVID-19 situation

Post COVID-19 situation

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Trigeminal Neuralgia Treatment market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Trigeminal Neuralgia Treatment market?

Which is the largest regional market for Trigeminal Neuralgia Treatment market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Trigeminal Neuralgia Treatment market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Trigeminal Neuralgia Treatment market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Trigeminal Neuralgia Treatment Market
  • 2.2. Global Trigeminal Neuralgia Treatment Market, By Treatment, 2021 (US$ Million)
  • 2.3. Global Trigeminal Neuralgia Treatment Market, By Geography, 2021 (US$ Million)
  • 2.4. Attractive Investment Proposition by Geography, 2021

3. Trigeminal Neuralgia Treatment Market: Competitive Analysis

  • 3.1. Market Positioning of Key Trigeminal Neuralgia Treatment Market Vendors
  • 3.2. Strategies Adopted by Trigeminal Neuralgia Treatment Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Trigeminal Neuralgia Treatment Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Trigeminal Neuralgia Treatment Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Drug Based
      • 5.3.1.1. Anticonvulsant
      • 5.3.1.2. NSAIDs
      • 5.3.1.3. Opioids
    • 5.3.2. Surgery
      • 5.3.2.1. Rhizotomy
      • 5.3.2.2. Stereotactic radiosurgery
      • 5.3.2.3. Micro vascular decompression

6. North America Trigeminal Neuralgia Treatment Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 6.3.Trigeminal Neuralgia Treatment Market: By Region, 2020-2030, USD (Million)
    • 6.3.1.North America
      • 6.3.1.1. U.S.
        • 6.3.1.1.1. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 6.3.1.2. Canada
        • 6.3.1.2.1. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 6.3.1.3. Rest of North America
        • 6.3.1.3.1. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)

7. UK and European Union Trigeminal Neuralgia Treatment Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 7.3.Trigeminal Neuralgia Treatment Market: By Region, 2020-2030, USD (Million)
    • 7.3.1.UK and European Union
      • 7.3.1.1. UK
        • 7.3.1.1.1. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 7.3.1.2. Germany
        • 7.3.1.2.1. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 7.3.1.3. Spain
        • 7.3.1.3.1. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 7.3.1.4. Italy
        • 7.3.1.4.1. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 7.3.1.5. France
        • 7.3.1.5.1. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 7.3.1.6. Rest of Europe
        • 7.3.1.6.1. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)

8. Asia Pacific Trigeminal Neuralgia Treatment Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 8.3.Trigeminal Neuralgia Treatment Market: By Region, 2020-2030, USD (Million)
    • 8.3.1.Asia Pacific
      • 8.3.1.1. China
        • 8.3.1.1.1. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 8.3.1.2. Japan
        • 8.3.1.2.1. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 8.3.1.3. India
        • 8.3.1.3.1. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 8.3.1.4. Australia
        • 8.3.1.4.1. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 8.3.1.5. South Korea
        • 8.3.1.5.1. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 8.3.1.6. Rest of Asia Pacific
        • 8.3.1.6.1. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)

9. Latin America Trigeminal Neuralgia Treatment Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 9.3.Trigeminal Neuralgia Treatment Market: By Region, 2020-2030, USD (Million)
    • 9.3.1.Latin America
      • 9.3.1.1. Brazil
        • 9.3.1.1.1. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 9.3.1.2. Mexico
        • 9.3.1.2.1. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 9.3.1.3. Rest of Latin America
        • 9.3.1.3.1. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)

10. Middle East and Africa Trigeminal Neuralgia Treatment Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 10.3.Trigeminal Neuralgia Treatment Market: By Region, 2020-2030, USD (Million)
    • 10.3.1.Middle East and Africa
      • 10.3.1.1. GCC
        • 10.3.1.1.1. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 10.3.1.2. Africa
        • 10.3.1.2.1. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 10.3.1.3. Rest of Middle East and Africa
        • 10.3.1.3.1. Trigeminal Neuralgia Treatment Market: By Treatment, 2020-2030, USD (Million)

11. Company Profile

  • 11.1. Allergan Plc
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Initiatives
  • 11.2. Biogen, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Initiatives
  • 11.3. Kineta Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Initiatives
  • 11.4. Merz Pharma GmbH & Co.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Initiatives
  • 11.5. Trigemina Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Initiatives
  • 11.6. Abbott Laboratories
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Initiatives
  • 11.7. Pfizer Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Initiatives
  • 11.8. GlaxoSmithKline Plc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Initiatives
  • 11.9. Novartis
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Initiatives
  • 11.10. Shire
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Portfolio
    • 11.10.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 2 Global Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 3 Global Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 4 North America Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 5 North America Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 6 North America Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 7 U.S. Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 8 U.S. Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 9 U.S. Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 10 Canada Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 11 Canada Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 12 Canada Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 13 Rest of North America Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 14 Rest of North America Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 15 Rest of North America Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 16 UK and European Union Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 17 UK and European Union Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 18 UK and European Union Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 19 UK Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 20 UK Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 21 UK Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 22 Germany Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 23 Germany Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 24 Germany Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 25 Spain Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 26 Spain Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 27 Spain Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 28 Italy Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 29 Italy Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 30 Italy Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 31 France Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 32 France Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 33 France Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 34 Rest of Europe Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 35 Rest of Europe Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 36 Rest of Europe Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 37 Asia Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 38 Asia Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 39 Asia Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 40 China Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 41 China Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 42 China Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 43 Japan Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 44 Japan Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 45 Japan Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 46 India Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 47 India Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 48 India Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 49 Australia Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 50 Australia Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 51 Australia Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 52 South Korea Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 53 South Korea Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 54 South Korea Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 55 Latin America Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 56 Latin America Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 57 Latin America Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 58 Brazil Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 59 Brazil Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 60 Brazil Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 61 Mexico Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 62 Mexico Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 63 Mexico Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 64 Rest of Latin America Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 65 Rest of Latin America Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 66 Rest of Latin America Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 67 Middle East and Africa Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 68 Middle East and Africa Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 69 Middle East and Africa Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 70 GCC Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 71 GCC Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 72 GCC Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 73 Africa Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 74 Africa Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 75 Africa Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Trigeminal Neuralgia Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Trigeminal Neuralgia Treatment Market By Drug Based, 2020-2030, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Trigeminal Neuralgia Treatment Market By Surgery, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Trigeminal Neuralgia Treatment Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Trigeminal Neuralgia Treatment Market: Quality Assurance
  • FIG. 5 Global Trigeminal Neuralgia Treatment Market, By Treatment, 2021
  • FIG. 6 Global Trigeminal Neuralgia Treatment Market, By Geography, 2021
  • FIG. 7 Market Geographical Opportunity Matrix - Global Trigeminal Neuralgia Treatment Market, 2021
  • FIG. 8 Market Positioning of Key Trigeminal Neuralgia Treatment Market Players, 2021
  • FIG. 9 Global Trigeminal Neuralgia Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 10 Global Trigeminal Neuralgia Treatment Market, By Treatment, 2021 Vs 2030, %
  • FIG. 11 U.S. Trigeminal Neuralgia Treatment Market (US$ Million), 2020 - 2030
  • FIG. 12 Canada Trigeminal Neuralgia Treatment Market (US$ Million), 2020 - 2030
  • FIG. 13 Rest of North America Trigeminal Neuralgia Treatment Market (US$ Million), 2020 - 2030
  • FIG. 14 UK Trigeminal Neuralgia Treatment Market (US$ Million), 2020 - 2030
  • FIG. 15 Germany Trigeminal Neuralgia Treatment Market (US$ Million), 2020 - 2030
  • FIG. 16 Spain Trigeminal Neuralgia Treatment Market (US$ Million), 2020 - 2030
  • FIG. 17 Italy Trigeminal Neuralgia Treatment Market (US$ Million), 2020 - 2030
  • FIG. 18 France Trigeminal Neuralgia Treatment Market (US$ Million), 2020 - 2030
  • FIG. 19 Rest of Europe Trigeminal Neuralgia Treatment Market (US$ Million), 2020 - 2030
  • FIG. 20 China Trigeminal Neuralgia Treatment Market (US$ Million), 2020 - 2030
  • FIG. 21 Japan Trigeminal Neuralgia Treatment Market (US$ Million), 2020 - 2030
  • FIG. 22 India Trigeminal Neuralgia Treatment Market (US$ Million), 2020 - 2030
  • FIG. 23 Australia Trigeminal Neuralgia Treatment Market (US$ Million), 2020 - 2030
  • FIG. 24 South Korea Trigeminal Neuralgia Treatment Market (US$ Million), 2020 - 2030
  • FIG. 25 Rest of Asia Trigeminal Neuralgia Treatment Market (US$ Million), 2020 - 2030
  • FIG. 26 Brazil Trigeminal Neuralgia Treatment Market (US$ Million), 2020 - 2030
  • FIG. 27 Mexico Trigeminal Neuralgia Treatment Market (US$ Million), 2020 - 2030
  • FIG. 28 Rest of Latin America Trigeminal Neuralgia Treatment Market (US$ Million), 2020 - 2030
  • FIG. 29 GCC Trigeminal Neuralgia Treatment Market (US$ Million), 2020 - 2030
  • FIG. 30 Africa Trigeminal Neuralgia Treatment Market (US$ Million), 2020 - 2030
  • FIG. 31 Rest of Middle East and Africa Trigeminal Neuralgia Treatment Market (US$ Million), 2020 - 2030